Sapacitabine (CS-682)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 16:19, 4 April 2013 by Jwarner (talk | contribs) (Created page with "=Preliminary results= ==Phase II== # Hagop Kantarjian, Stefan Faderl, Guillermo Garcia-Manero, Selina Luger, Parameswaran Venugopal, Lori Maness, Meir Wetzler, Steven Coutre,...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Preliminary results

Phase II

  1. Hagop Kantarjian, Stefan Faderl, Guillermo Garcia-Manero, Selina Luger, Parameswaran Venugopal, Lori Maness, Meir Wetzler, Steven Coutre, Wendy Stock, David Claxton, Stuart L Goldberg, Martha Arellano, Stephen A Strickland, Karen Seiter, Gary Schiller, Elias Jabbour, Judy Chiao, William Plunkett, Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study, The Lancet Oncology, Volume 13, Issue 11, November 2012, Pages 1096-1104, ISSN 1470-2045, 10.1016/S1470-2045(12)70436-9. link to article